fMRI Neurofeedback for Faster PTSD Symptom Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for post-traumatic stress disorder (PTSD) are inadequate in achieving significant reductions in symptom severity, particularly in CAPS-5 scale scores, within a reasonable time frame.

Innovation Solution

A neurofeedback (NF) treatment approach that modulates the activation of the Amygdala or related brain regions using functional magnetic resonance imaging (fMRI) to train patients, combined with EEG signal recording and feedback, to achieve a reduction in PTSD symptoms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current PTSD treatments are used, then treatment is provided to patients, but significant reduction in CAPS-5 scale scores is not achieved within a reasonable time frame

Engineering Contradiction:
Improvesymptom reduction rateVSAvoidtreatment duration
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent employs real-time fMRI neurofeedback where patients receive immediate visual feedback about their amygdala activation levels during scanning. This allows patients to learn self-regulation of their brain activity, achieving significant CAPS-5 score reductions (average 24.6 points) within 10 sessions over 2-3 months, thereby improving both treatment productivity and time efficiency compared to conventional therapies

Inventive Principle:
Principle #23Feedback

2Reliability

If fMRI neurofeedback treatment is delivered, then CAPS-5 scale scores are significantly reduced, but treatment complexity increases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidtreatment system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses a computer-generated visual feedback interface as an intermediary between the fMRI scanner and the patient. This mediator translates complex amygdala activation data into simple, intuitive visual displays (e.g., animated characters or bars) that patients can easily understand and respond to, thereby maintaining high treatment effectiveness while reducing the perceived complexity for patients

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system creates a virtual copy or representation of the patient's amygdala activity in the form of visual feedback images. Instead of directly manipulating complex brain activity, patients interact with this simplified visual copy, making the treatment more accessible and easier to administer while maintaining scientific rigor

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The NF treatment method effectively reduces CAPS-5 scale scores by at least 6 points within 8 to 12 weeks, and up to 3 months, providing a measurable improvement in PTSD symptomatology.

Implementation Method 1

functional magnetic resonance imaging (fMRI) to train patients

Methodology Applied
Scientific EffectBlood oxygen level-dependent (BOLD) contrast:

Implementation Method 2

recording EEG signals from said selected population

Methodology Applied
Scientific EffectElectroencephalography (EEG):

Implementation Method 3

providing feedback to said population regarding an activity of said Amygdala

Methodology Applied
Scientific EffectNeurofeedback: Feedback

Data Source

PatentUS20260053421A1Post traumatic stress disorder treatment
Publication Date: 2026.02.26 GRAYMATTERS HEALTH
  • US20260053421A1 patent drawing
  • US20260053421A1 patent drawing
  • US20260053421A1 patent drawing

AI summary

A method to treat a predetermined patient population for post traumatic stress disorder (PTSD), the method including:selecting a population of patients diagnosed with PTSD;delivering a NF treatment to the population;achieving a reduction of at least 6 points in average in a CAPS-5 scale in the selected population, after a time period between 8 weeks and 12 weeks of the delivering.